Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5;23(1):140.
doi: 10.1186/s12886-023-02888-3.

Analyzing the demographics of patients with uveitis in an indigent, urban population

Affiliations

Analyzing the demographics of patients with uveitis in an indigent, urban population

Caroline W Tipton et al. BMC Ophthalmol. .

Abstract

Purpose: To study the types of uveitis examined in a hospital serving indigent populations in need of low-cost care.

Methods: A retrospective chart review examined the electronic medical records of all patients with uveitis-related at Drexel Eye Physicians. Data collected included demographics, anatomic location of the uveitis, systemic disease associations, treatment modalities and insurance. Statistical analysis was performed using χ² or Fischer exact tests.

Results: 270 patients (366 eyes) were included for analysis, 67% of patients identified as African American. Most eyes (95.3%, N = 349) were treated with topical corticosteroid drops, and only 6 (1.6%) received an intravitreal implant. Immunosuppressive medications were started in 24 patients (8.9%). Nearly 80% depended to some extent on Medicare or Medicaid Assistance for treatment coverage. There was no association between insurance type and use of biologics or difluprednate.

Conclusion: We found no association between insurance type and the prescription of medications for uveitis that should be used at home. There was a minimal number of patients prescribed medications for implantation in the office. The adherence of use of medications at home should be investigated.

Keywords: Indigent; Low-cost care; Philadelphia; Uveitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

References

    1. Jabs DA. Immunosuppression for the uveitides. Ophthalmology. 2018 Feb;125(2):193–202. - PMC - PubMed
    1. Smith JR, Rosenbaum JT. Management of immune-mediated uveitis. BioDrugs. 2000;13(1):9–20. doi: 10.2165/00063030-200013010-00002. - DOI - PubMed
    1. Jabs DA, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513. doi: 10.1016/S0002-9394(00)00659-0. - DOI - PubMed
    1. Agrawal H, et al. Systemic immunosuppressive therapies for uveitis in developing countries. Indian J Ophthalmol. 2020;68(9):1852–62. doi: 10.4103/ijo.IJO_1548_20. - DOI - PMC - PubMed
    1. Adán-Civera AM, et al. Burden and direct costs of non-infectious uveitis in Spain. Reumatol Clin. 2016;12(4):196–200. doi: 10.1016/j.reuma.2015.08.004. - DOI - PubMed

Substances